| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/03/1997 | US5635187 Adding phytogenic compounds to storage solution to increase organ preservation for transplantation |
| 06/03/1997 | US5635186 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 06/03/1997 | US5635177 Useful in enabling role of tyrosine kinase receptor in cell growth and differentiation |
| 06/03/1997 | CA2077651C Peptides stimulating cytotoxic t cells immune to hiv rt |
| 05/29/1997 | WO1997019194A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE |
| 05/29/1997 | WO1997019177A1 SYNTHETIC MAMMALIAN α-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME |
| 05/29/1997 | WO1997019176A1 Malathion carboxylesterase |
| 05/29/1997 | WO1997019171A1 Epithelial membrane protein-1 |
| 05/29/1997 | WO1997019170A1 Receptor and nucleic acid molecule encoding said receptor |
| 05/29/1997 | WO1997019169A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | WO1997019167A1 Nucleic acid molecule encoding a 11-cis retinol dehydrogenase |
| 05/29/1997 | WO1997019110A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | WO1997018842A1 A biologic material comprising an efficient culture of bone marrow stem cells partially or completely differentiated into connective tissue cells and a three-dimensional biocompatible and biodegradable matrix consisting of a hyaluronic acid derivative |
| 05/29/1997 | WO1997018841A1 Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018828A1 Inhibitors of cyclophilin rotamase activity |
| 05/29/1997 | WO1997018822A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | WO1997018703A1 Method for constructing transgenic animals |
| 05/29/1997 | WO1996039812A3 Cryopreservation of diverse plant cells |
| 05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238290A1 Methods for determining compounds capable of inhibiting the activities of the ha-ras oncogene |
| 05/29/1997 | CA2238176A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | CA2238010A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | CA2236162A1 Epithelial membrane protein-1 |
| 05/28/1997 | EP0775747A2 Genes of the hop latent virus and methods for detecting the same |
| 05/28/1997 | EP0775743A2 Sustainable chick cell line infected with Marek's disease virus |
| 05/28/1997 | EP0775742A2 Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775212A2 Control of plant gene expression |
| 05/28/1997 | EP0775211A1 Fumonisin detoxification enzymes |
| 05/28/1997 | EP0775200A1 Recombinant kat enzyme and process for its preparation |
| 05/28/1997 | EP0775197A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor |
| 05/28/1997 | EP0688430B1 Immobilisation and separation of cells and other particles |
| 05/28/1997 | EP0674734B1 Ski slope maintenance device |
| 05/28/1997 | EP0670890B1 Bioreactor with immobilized lactic acid bacteria and the use thereof |
| 05/28/1997 | EP0517918B1 Monoclonal antibody against cardiac glycoside and utilization thereof |
| 05/28/1997 | EP0512112B1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 05/28/1997 | EP0472522B1 Method for screening cells or formed bodies with populations expressing selected characteristics |
| 05/28/1997 | EP0403554B1 Placental isoferritins for the prognosis and diagnosis of immunosuppression |
| 05/28/1997 | CN1150820A Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 05/28/1997 | CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/28/1997 | CN1150764A Polymeric microbeads and method of preparation |
| 05/28/1997 | CN1150754A Human osteoclast-derived cathepsin |
| 05/27/1997 | US5633448 For conferring to plants an increased tolerance to glyphosate |
| 05/27/1997 | US5633442 Method of producing pathogen-resistant plants |
| 05/27/1997 | US5633348 Amphotropic virus receptor |
| 05/27/1997 | US5633234 Lysosomal targeting of immunogens |
| 05/27/1997 | US5633162 Method for culturing Chinese hamster ovary cells |
| 05/27/1997 | US5633145 TNFα receptor-derived binding protein |
| 05/27/1997 | US5632994 Fas associated proteins |
| 05/27/1997 | US5632993 Immunogens and the use thereof for obtaining antibodies against HbA1c |
| 05/27/1997 | US5632778 Treated tissue for implantation and methods of preparation |
| 05/27/1997 | CA1339047C Production of erythropoietin |
| 05/22/1997 | WO1997018475A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 05/22/1997 | WO1997018473A1 Method and apparatus for bulk enrichment of a population or subpopulation of cells |
| 05/22/1997 | WO1997018333A1 Disruption of expression of multiple alleles of mammalian genes |
| 05/22/1997 | WO1997018315A1 Hybrid factor viii with modified activity |
| 05/22/1997 | WO1997018306A1 Crf analogs and their use in photoaffinity labeling of crf receptors |
| 05/22/1997 | WO1997018302A1 METHOD OF PRODUCING α2,3-SIALYLTRANSFERASE |
| 05/22/1997 | WO1997018300A2 Murine model for human carcinoma |
| 05/22/1997 | WO1997018299A1 In vitro chondrogenic induction of human mesenchymal stem cells |
| 05/22/1997 | WO1997018298A1 Ex vivo culture of stem cells |
| 05/22/1997 | WO1997018297A1 Functional human hematopoietic cells |
| 05/22/1997 | WO1997018296A1 Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics |
| 05/22/1997 | WO1997018241A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 05/22/1997 | WO1997018232A2 Peptides derived from the oncogene proteine bcr-abl expressed by leukemic cells and utilisation thereof for the therapy of human leukemiae |
| 05/22/1997 | WO1997018230A1 Cloning and expression of beta app-c100 receptor (c100-r) |
| 05/22/1997 | WO1997017983A1 Methods of treating disorders of non-visual sensory epithelia |
| 05/22/1997 | WO1997017842A1 Production of somatic mosaicism in mammals using a recombinatorial substrate |
| 05/22/1997 | WO1997012961A3 Growth of adult pancreatic islet cells with laminin 5 |
| 05/22/1997 | WO1997005252A3 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 05/22/1997 | WO1997005241A3 Methods and compositions for identifying morphogen analogs |
| 05/22/1997 | WO1996038567A3 Dna sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides |
| 05/22/1997 | CA2238007A1 Cloning and expression of .beta.app-c100 receptor (c100-r) |
| 05/22/1997 | CA2237862A1 Method of producing .alpha.2,3-sialyltransferase |
| 05/22/1997 | CA2237548A1 Crf analogs and their use in photoaffinity labeling of crf receptors |
| 05/22/1997 | CA2237392A1 Production of somatic mosaicism in mammals using a recombinatorial substrate |
| 05/22/1997 | CA2237391A1 Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics |
| 05/22/1997 | CA2236871A1 Method and apparatus for bulk enrichment of a population or subpopulation of cells |
| 05/22/1997 | CA2235695A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 05/22/1997 | CA2235628A1 Hybrid factor viii with modified activity |
| 05/22/1997 | CA2210650A1 Cell cycle checkpoint pik-related kinase materials and methods |
| 05/21/1997 | EP0774510A1 Ungulate eg cell |
| 05/21/1997 | EP0774007A1 Production of oligosaccharides in transgenic plants |
| 05/21/1997 | EP0774005A1 Surface expression of enzyme in gene directed prodrug therapy |
| 05/21/1997 | EP0774004A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 05/21/1997 | EP0774003A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 05/21/1997 | EP0773997A2 Htk ligand |
| 05/21/1997 | EP0773995A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof |
| 05/21/1997 | EP0773993A1 Genetically engineered swine cells |
| 05/21/1997 | EP0773989A1 Method for measuring hormones in biological samples |
| 05/21/1997 | EP0773962A1 Antibodies which activate an erythropoietin receptor |
| 05/21/1997 | EP0773960A1 POLYPEPTIDES WITH Fc BINDING ABILITY |
| 05/21/1997 | EP0773959A1 Adrenergic receptor |
| 05/21/1997 | EP0773957A2 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| 05/21/1997 | EP0773952A1 Interaction trap systems for detecting protein interactions |
| 05/21/1997 | EP0650377A4 Implanting devices for release of neuroinhibitory compounds. |
| 05/21/1997 | EP0527821B1 Oxidation resistant thrombomodulin analogs |
| 05/21/1997 | EP0491875B1 Recombinant dna method and vectors for use therein |